Alveolar macrophages are essential for the maintenance of surfactant homeos
tasis. We asked whether surfactant treatment would change alveolar macropha
ge number and whether the alveolar macrophage phenotype would become activa
ted or apoptotic when challenged in vivo with exogenous surfactant. Surfact
ant pool size in mice was increased by repetitive surfactant treatments con
taining 120 mg/kg (110 mmol/kg) saturated phosphatidylcholine. The number o
f alveolar macrophages recovered by alveolar lavage decreased after the fir
st dose by 49% and slightly increased after the second and third doses. Up
to 28.5% of the macrophages became large and foamy, and their appearance no
rmalized within 12 h. Surfactant treatment did not increase the percent of
apoptotic or necrotic cells. The alveolar macrophages were not activated as
indicated by no change in expression of CD14, CD16, CD54, CD95, and scaven
ger receptor class A types I and II after surfactant treatment. Surfactant
treatment in healthy mice transiently changed the phenotype of alveolar mac
rophages to large and foamy without indications of changes in the surface m
arkers characteristic of activation.